B.C. pharmaceutical company’s stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Saanich-based pharmaceutical company, Aurinia Pharmaceuticals, saw share values soar on Thursday after success with clinical trials for a new lupus drug.

On Dec. 4, the company announced that results from the AURORA Phase 3 drug trials for voclosporin had been successful in treating kidney inflammation in patients with lupus nephritis – an autoimmune disease.

Aurinia’s chief medical officer Neil Solomons explained that patients with lupus can experience “irreversible kidney damage” that can lead to kidney failure and death.

READ ALSO: Saanich biotech company secures $52M US for global drug study

The study included 357 patients from around the world with lupus and the results showed that participants using voclosporin experienced a “renal response rate” of 40.8 per cent while just 22.5 per cent of participants in the control group – those who didn’t receive the drug – saw improvements.

Data also indicated that the group taking voclosporin saw no more adverse events than the group receiving standard lupus treatment, noted Brad Rovin, chief of the nephrology division at the Ohio State University Wexner Medical Centre.

Following the announcement of the drug’s successful Phase 3 trial, the company’s share price exploded on Thursday, rising from Wednesday’s close of $11.13 per share to touch a 52-week high of $23.04 before closing at $19.75. Its shares have risen from a 52-week low of $4.70 to close Friday at $20.48 – a gain of 336 per cent, driving the company’s market cap to $1.93 billion.

READ ALSO: Mental health call temporarily shuts down Trans Canada Highway in View Royal

Lupus has historically been difficult to treat and new treatment options were needed, said Stevan Gibson, president and CEO of the Lupus Foundation of America. Voclosporin is the first effective therapeutic treatment option and the successful trial marks a step forward in treating the potentially deadly disease, he noted.

Chief executive Peter Greenleaf noted that staff were “thrilled with the outcomes” of the trial and that the drug’s success is significant for people living with lupus – close to 3 million people worldwide. The company is planning to put the drug on the market as early as 2021, but first it must pass though the U.S. Food and Drug Administration (FDA) process. The drug was given a fast track by the FDA in 2016 and the company plans to submit to the FDA in early 2020.

With files from Paul Bucci.


@devonscarlett
Like us on Facebook and follow us on Twitter.

devon.bidal@saanichnews.com

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Comments are closed

Just Posted

‘Justice for Mona’ protests planned in Kelowna, Lower Mainland

Security camera footage shows Mona Wang being dragged, stepped on during RCMP wellness check

Mini prom celebrates 13 Lake Country grads

Grad’s sister marks occasion with small prom for close friends from quarantine Class of 2020 amid COVID-19

Orphaned Okanagan beavers admitted to rehab centre

The two beavers are in the care of the Fawcett Family Wildlife Health Centre

Car smashes into Kelowna dollar store

The vehicle went through the front window of the store just off Highway 97 North

Interior Health will not expand Police and Crisis Team

Southeast Division Chief Superintendent Brad Haugli asked IH to expand the program

13 new B.C. COVID-19 cases, Langley Lodge outbreak ends

Health care outbreaks down to four, 162 cases active

Okanagan Realtors donate big to North Westside fire department

Two Kelowna-area Realtors made a generous donation to the North Westside Fire… Continue reading

SilverStar security recovers stolen bike

Reminders to residents to keep bicycles locked up, eyes open for suspicious activity

Intent of killing at centre of Surrey man’s Okanagan murder trial

B.C. Supreme Court Justice Allison Beames is anticipated to return with her decision in August

Kelowna neighbourhood pond dries up again

The RDCO filled up the pond on Hall Road but it’s drying up again

Penticton RCMP seek help locating missing woman

25-year-old Iesha Blomquist was reported missing to Penticton RCMP on June 30

Majority of residents in support of alcohol in outdoor spaces: City of Penticton

City council will vote on whether to continue allowing public consumption, on Tuesday, July 7

Princeton RCMP arrest suspects in violent Salmon Arm home invasion

Two men who allegedly staged a violent home invasion in Salmon Arm… Continue reading

Most Read